SEC filing · 10-Q

Celularity Inc: Quarterly report

Celularity reported a 66.3% drop in quarterly revenue and noted substantial doubt regarding its ability to continue as a going concern.

Filed September 29, 2026 · period ended March 31, 2026

Negative for the company

What the numbers say

Revenue fell 66% to $3.8M versus the same quarter last year (6.3% down on the previous quarter); operating margin narrowed from -91.8% to -263.5%; diluted EPS $0.02 versus -$0.84; cash fell by $5.8M to $368K; diluted share count up 29% (dilution).

Compared with the same period a year earlier, from the figures Celularity Inc reported to the SEC.

What happened

Total revenues fell to $3,846 thousand for the first quarter of 2026 from $11,426 thousand in the prior year period, led by a 90.4% decline in product sales.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Celularity Inc

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.